Sandra Wagner Selected Research

Fibrosis (Cirrhosis)

3/2006

Inhibition of hepatic fibrogenesis by matrix metalloproteinase-9 mutants in mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Sandra Wagner Research Topics

Disease

4	Neoplasms (Cancer) 12/2020 - 04/2002
3	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 01/2017
3	Hypertension (High Blood Pressure) 10/2020 - 01/2017
3	Chronic Renal Insufficiency 10/2017 - 04/2017
2	Metabolic Diseases (Metabolic Disease) 01/2022 - 01/2017
2	Colorectal Neoplasms (Colorectal Cancer) 09/2021 - 12/2018
2	Melanoma (Melanoma, Malignant) 01/2019 - 12/2018
2	Carcinogenesis 12/2017 - 11/2006
2	Chronic Kidney Failure (Chronic Renal Failure) 10/2017 - 09/2017
2	Inflammation (Inflammations) 01/2015 - 04/2013
1	Hyperphosphatemia 01/2022
1	Hyperuricemia 01/2022
1	Presbyopia 01/2022
1	Prediabetic State (Prediabetes) 01/2022
1	Heart Failure 01/2022
1	Neoplasm Metastasis (Metastasis) 09/2021
1	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 10/2020
1	Medulloblastoma 01/2019
1	Brain Neoplasms (Brain Tumor) 01/2019
1	Hyponatremia 01/2019
1	Primitive Neuroectodermal Tumors (PNET) 01/2019
1	Overweight 01/2018
1	Weight Loss (Weight Reduction) 05/2017
1	Myopia 02/2015
1	Refractive Errors (Refractive Error) 02/2015
1	Lung Diseases (Lung Disease) 04/2013
1	Brain Diseases (Brain Disorder) 08/2009
1	Infections 01/2008
1	Crohn Disease (Crohn's Disease) 11/2006
1	Ulcerative Colitis 11/2006
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 11/2006
1	Adenomatous Polyps 11/2006
1	Fibrosis (Cirrhosis) 03/2006
1	Autolysis 04/2005
1	Hepatocellular Carcinoma (Hepatoma) 02/2005
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 04/2002
1	Leukemia 04/2002

Drug/Important Bio-Agent (IBA)

2	Proteins (Proteins, Gene)FDA Link 01/2022 - 03/2006
2	CreatinineIBA 10/2020 - 04/2017
2	p-Aminohippuric Acid (p-Aminohippurate)FDA Link 10/2017 - 09/2017
2	PotassiumIBA 10/2017 - 09/2017
2	Iohexol (Omnipaque)FDA Link 05/2017 - 04/2017
2	Tissue Inhibitor of Metalloproteinase-1IBA 11/2006 - 03/2006
2	Messenger RNA (mRNA)IBA 11/2006 - 03/2006
1	pro-brain natriuretic peptide (1-76)IBA 01/2022
1	Natriuretic PeptidesIBA 01/2022
1	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2022
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2022
1	Biomarkers (Surrogate Marker)IBA 01/2022
1	ORALIT (ORS)IBA 01/2022
1	C-Reactive ProteinIBA 01/2022
1	Genetic Markers (Genetic Marker)IBA 01/2022
1	Hormones (Hormone)IBA 01/2022
1	Irinotecan (Camptosar)FDA LinkGeneric 09/2021
1	Pharmaceutical PreparationsIBA 09/2021
1	CytosineIBA 12/2020
1	DNA (Deoxyribonucleic Acid)IBA 12/2020
1	Antiviral Agents (Antivirals)IBA 12/2020
1	Uric Acid (Urate)IBA 10/2020
1	AlbuminsIBA 10/2020
1	Phenobarbital (Luminal)FDA Link 01/2019
1	Phosphotransferases (Kinase)IBA 01/2019
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2019
1	Aquaporin 2IBA 01/2019
1	Carcinoembryonic AntigenIBA 12/2018
1	Cancer VaccinesIBA 12/2018
1	Protein Subunit VaccinesIBA 12/2018
1	Immune Checkpoint InhibitorsIBA 12/2018
1	AntigensIBA 12/2018
1	chemotactic factor inactivatorIBA 01/2018
1	AcetyltransferasesIBA 12/2017
1	Rosuvastatin Calcium (Crestor)FDA Link 01/2017
1	ElectrolytesIBA 01/2017
1	EnzymesIBA 01/2017
1	GlucocorticoidsIBA 01/2017
1	Oxidoreductases (Dehydrogenase)IBA 01/2017
1	oxidized low density lipoproteinIBA 01/2017
1	omega-Chloroacetophenone (Mace)IBA 01/2017
1	Hydrocortisone (Cortisol)FDA LinkGeneric 01/2017
1	ImmunosorbentsIBA 01/2017
1	Interferon-gamma (Interferon, gamma)IBA 01/2015
1	XenobioticsIBA 01/2015
1	MicroRNAs (MicroRNA)IBA 04/2013
1	Environmental Pollutants (Pollutants, Environmental)IBA 04/2013
1	Biological ProductsIBA 04/2013
1	Sigma FactorIBA 01/2008
1	Matrix Metalloproteinases (MMPs)IBA 11/2006
1	Indicators and Reagents (Reagents)IBA 11/2006
1	Hydroxyproline (4 Hydroxyproline)IBA 03/2006
1	Peptides (Polypeptides)IBA 04/2005
1	Anti-Bacterial Agents (Antibiotics)IBA 04/2005
1	NisinIBA 04/2005
1	Tissue Inhibitor of MetalloproteinasesIBA 02/2005
1	GelatinasesIBA 02/2005
1	Valproic Acid (Depakote)FDA LinkGeneric 04/2002
1	Histone Deacetylase InhibitorsIBA 04/2002

Therapy/Procedure

5	Therapeutics 09/2021 - 08/2009
1	Optical Devices 01/2022
1	Bariatric Surgery 05/2017
1	Hydrophilic Contact Lenses (Hydrophilic Contact Lens) 02/2015